Detalhe da pesquisa
1.
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis.
Rheumatology (Oxford)
; 60(3): 1137-1147, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32864685
2.
Open-Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed Therapy With Apremilast.
J Drugs Dermatol
; 17(10): 1078-1082, 2018 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30365588
3.
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission.
Arthritis Rheumatol
; 73(5): 759-768, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33205906
4.
Decreased Injection Site Pain Associated with Phosphate-Free Etanercept Formulation in Rheumatoid Arthritis or Psoriatic Arthritis Patients: A Randomized Controlled Trial.
Rheumatol Ther
; 6(2): 245-254, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30915626
5.
Measurement properties of the minimal disease activity criteria for psoriatic arthritis.
RMD Open
; 5(2): e001002, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31565243
6.
Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial.
Arthritis Rheumatol
; 71(7): 1112-1124, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30747501
7.
Toward Accelerated Authorization and Access to New Medicines for Juvenile Idiopathic Arthritis.
Arthritis Rheumatol
; 71(12): 1976-1984, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31313532
8.
Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA).
RMD Open
; 4(1): e000606, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29531787
9.
Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis.
Arthritis Rheumatol
; 70(7): 1071-1076, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29513931
10.
Retrospective analysis to describe associations between tumor necrosis factor alpha inhibitors and COPD-related hospitalizations.
Int J Chron Obstruct Pulmon Dis
; 12: 2085-2094, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28790811
11.
Brief Report: Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus Erythematosus.
Arthritis Rheumatol
; 69(5): 1028-1034, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28118537
12.
Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis.
Lupus Sci Med
; 4(1): e000226, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29018537
13.
Reply.
Arthritis Rheumatol
; 73(9): 1771-1772, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33750019
14.
Reply.
Arthritis Rheumatol
; 72(7): 1229-1230, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32266796
15.
Blockade of interferon-γ normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus.
Arthritis Rheumatol
; 67(10): 2713-22, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26138472
16.
A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis.
Arthritis Res Ther
; 15(5): R164, 2013 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-24286136
17.
Transitional B cells: step by step towards immune competence.
Trends Immunol
; 24(6): 343-9, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12810111
18.
CD23 defines two distinct subsets of immature B cells which differ in their responses to T cell help signals.
Int Immunol
; 14(2): 157-66, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11809735
19.
Cost-effectiveness analysis of the Lyme disease vaccine.
Arthritis Rheum
; 46(6): 1651-60, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12115198
20.
Incomplete activation of CD4 T cells by antigen-presenting transitional immature B cells: implications for peripheral B and T cell responsiveness.
J Immunol
; 171(4): 1758-67, 2003 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12902475